telmisartan has been researched along with Diabetes Mellitus in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 20 (58.82) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, N; Cheng, F; Cummings, J; Gao, S; Hou, Y; Leverenz, JB; Pieper, AA; Tu, W; Zhang, P | 1 |
| Gaikwad, AB; Kale, A; Sankrityayan, H; Shelke, V | 1 |
| Chatterjee, B; Pal, TK; Sengupta, P | 1 |
| Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Marx, N; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S | 1 |
| Fan, YM; Gao, DF; Li, YQ; Qin, XJ; Wu, JJ; Zhang, Y | 1 |
| Cho, DH; Jo, I; Kim, SA; Park, JH; Park, JY; Seo, J; Song, KH | 1 |
| Aswar, M; Aswar, U; Chepurwar, S; Shintre, S | 1 |
| Alhamdani, MS; Daiber, A; Debrezion, J; Fleming, I; Hortmann, M; Müller, J; Münzel, T; Oelze, M; Reifenberg, K; Schuhmacher, S; Schulz, E; Wenzel, P | 1 |
| Kurtz, TW | 1 |
| Banas, B; Büchner, N; Krämer, BK | 1 |
| Budaj, A; Chaithiraphan, S; Dickstein, K; Dyal, L; Keltai, M; Maggioni, A; Mann, JF; McQueen, M; Metsärinne, K; Oto, A; Parkhomenko, A; Piegas, LS; Pogue, J; Schmieder, RE; Schumacher, H; Svendsen, TL; Teo, KK; Wang, X; Yusuf, S | 1 |
| Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; VanderMaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S | 1 |
| Anderson, C; Cukierman-Yaffe, T; Gerstein, HC; Hilbrich, L; Jackson, SH; Sleight, P; Teo, K; Yusuf, S; Zhao, F | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Weber, MA | 1 |
| Hoogwerf, BJ | 1 |
| Kjeldsen, SE; Mancia, G; Schmieder, RE; Unger, T | 1 |
| Davidai, G; Henry, R; Hsueh, W; Mudaliar, S | 1 |
| Barzilay, JI; Commerford, P; Dans, A; Ferreira, R; Gao, P; Keltai, M; Paolasso, E; Probstfield, J; Rydén, L; Schumacher, H; Teo, K; Yusuf, S | 1 |
| Fujishima, H; Fujita, H; Hosoba, M; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, K; Takahashi, T; Yamada, Y | 1 |
| Akhrass, PR; McFarlane, SI | 1 |
| Danser, AH; Maggioni, AP; Menard, J; Mueller, DN; Ruilope, LM; Volpe, M; Waeber, B | 1 |
| Fujimoto, M; He, P; Honjo, S; Ishibashi, R; Ishikawa, T; Koshizaka, M; Mezawa, M; Okabe, E; Onishi, S; Saito, Y; Sato, S; Takemoto, M; Tokuyama, H; Tsurutani, Y; Ueda, S; Yokote, K | 1 |
| Balakumar, P; Bishnoi, HK; Mahadevan, N | 2 |
| Fukuda, D; Hirata, Y; Kurobe, H; Maeda, N; Masuzaki, H; Sakaue, H; Sata, M; Sato, H; Shimabukuro, M; Shimomura, I; Shiota, A; Soeki, T; Uematsu, E | 1 |
| Ando, H; Fujimura, A; Ushijima, K | 1 |
| Ando, H; Fujimura, A; Ishikawa-Kobayashi, E; Maekawa, T; Nozawa, M; Shiga, T; Takuma, M; Ushijima, K | 1 |
| Avezum, A; Dagenais, G; Dans, T; Dehghan, M; Gao, P; Mente, A; Probstfield, JL; Sleight, P; Teo, KK; Yusuf, S | 1 |
| Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM | 1 |
| Anderson, C; Hilbrich, L; Mookadam, F; Pogue, J; Ramos, B; Schumacher, H; Sleight, P; Teo, K; Yusuf, S | 1 |
| Takeuchi, M; Yamagishi, S | 1 |
| Abiko, A; Makita, S; Moriai, Y; Naganuma, Y; Nakamura, M | 1 |
| Anderson, C; Copland, I; Dagenais, G; Dyal, L; Pogue, J; Schumacher, H; Sleight, P; Teo, KK; Yusuf, S | 1 |
7 review(s) available for telmisartan and Diabetes Mellitus
| Article | Year |
|---|---|
Beyond the classic angiotensin-receptor-blocker profile.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Humans; Metabolic Syndrome; PPAR gamma; Receptor, Angiotensin, Type 1; Telmisartan | 2008 |
Telmisartan in high-risk cardiovascular patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Humans; Kidney Diseases; Ramipril; Risk Factors; Telmisartan | 2010 |
Renin-angiotensin system blockade and cardiovascular and renal protection.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Telmisartan | 2010 |
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Black People; Comorbidity; Diabetes Mellitus; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2010 |
Telmisartan and cardioprotection.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypertension; Risk; Telmisartan | 2011 |
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Complications; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Telmisartan | 2012 |
Telmisartan in the management of diabetic nephropathy: a contemporary view.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension; Kidney Diseases; Male; Telmisartan; Treatment Outcome | 2012 |
9 trial(s) available for telmisartan and Diabetes Mellitus
| Article | Year |
|---|---|
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hypertension; Myocardial Infarction; Peripheral Arterial Disease; Ramipril; Retrospective Studies; Risk Factors; Stroke; Systole; Telmisartan | 2019 |
[The impact of telmisartan on angiotensin converting enzyme 2 mRNA expression in monocyte-derived macrophages of diabetic hypertensive patients].
Topics: Aged; Angiotensin-Converting Enzyme 2; Benzimidazoles; Benzoates; Diabetes Mellitus; Female; Humans; Hypertension; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; RNA, Messenger; Telmisartan | 2013 |
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Middle Aged; Proteinuria; Ramipril; Telmisartan | 2008 |
Telmisartan to prevent recurrent stroke and cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Potassium; Secondary Prevention; Stroke; Telmisartan; Treatment Failure | 2008 |
Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Obesity; Overweight; Telmisartan | 2010 |
Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Fasting; Female; Glucose Intolerance; Humans; Male; Middle Aged; Telmisartan | 2011 |
Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries.
Topics: Aged; Benzimidazoles; Benzoates; Cardiovascular Agents; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Diet; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Male; Middle Aged; Prospective Studies; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Surveys and Questionnaires; Telmisartan | 2012 |
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmi
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Patient Selection; Ramipril; Randomized Controlled Trials as Topic; Research Design; Telmisartan | 2004 |
Telmisartan, ramipril, or both in patients at high risk for vascular events.
Topics: Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ramipril; Risk; Telmisartan | 2008 |
18 other study(ies) available for telmisartan and Diabetes Mellitus
| Article | Year |
|---|---|
Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
Topics: Alzheimer Disease; Black or African American; Diabetes Mellitus; Genome-Wide Association Study; Humans; Hypertension; Mendelian Randomization Analysis; Middle Aged; Telmisartan | 2023 |
Evaluating the potential of tauroursodeoxycholic acid as add-on therapy in amelioration of streptozotocin-induced diabetic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus; Diabetic Nephropathies; Rats; Rats, Wistar; Streptozocin; Taurochenodeoxycholic Acid; Telmisartan | 2023 |
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus; Drug Therapy, Combination; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Thiazolidinediones | 2017 |
Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cattle; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Humans; Hyperglycemia; I-kappa B Kinase; Inflammation; Monocytes; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
Telmisartan attenuates diabetes induced depression in rats.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzimidazoles; Benzoates; Brain; Depression; Depressive Disorder; Diabetes Mellitus; Diabetes Mellitus, Experimental; Female; Fluoxetine; Hydrocortisone; Interleukin-1beta; Interleukin-6; Male; Metformin; Nitric Oxide; Pilot Projects; Rats; Rats, Wistar; Renin-Angiotensin System; Streptozocin; Swimming; Telmisartan | 2017 |
AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Body Weight; Diabetes Mellitus; Enzyme Activation; GTP Cyclohydrolase; Male; Mitochondria; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Telmisartan; Up-Regulation | 2008 |
Telmisartan, ramipril, or both in patients at high risk of vascular events.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus; Drug Therapy, Combination; Humans; Ramipril; Telmisartan | 2008 |
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Cardiovascular Diseases; Cognition; Cognition Disorders; Cross-Sectional Studies; Depression; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan | 2009 |
Proteinuria: Is the ONTARGET renal substudy actually off target?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney; Multicenter Studies as Topic; Proteinuria; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2009 |
Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
Topics: Acetophenones; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Chemical Analysis; Blood Glucose; Blotting, Western; Diabetes Mellitus; Diabetic Nephropathies; Dinoprostone; Enzyme Inhibitors; Hyperglycemia; Immunohistochemistry; Kidney; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; NF-E2-Related Factor 2; Superoxide Dismutase; Superoxides; Telmisartan | 2012 |
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Calcium-Binding Proteins; Cells, Cultured; Diabetes Mellitus; Diabetic Nephropathies; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kidney Glomerulus; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Receptor, Notch1; Serrate-Jagged Proteins; Signal Transduction; Telmisartan; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2012 |
The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Creatine; Diabetes Mellitus; Diabetic Nephropathies; Drug Therapy, Combination; Female; Fenofibrate; Hypolipidemic Agents; Kidney; Lipids; Male; Nitrogen; Oxidative Stress; PPAR alpha; Proteinuria; Rats; Rats, Wistar; Streptozocin; Telmisartan | 2012 |
Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
Topics: Adipocytes; Administration, Oral; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Acid Transport Proteins; Glucose Transporter Type 4; Hypertrophy; Insulin; Islets of Langerhans; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; NAD; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; PPAR gamma; RNA, Messenger; Signal Transduction; Sirtuin 1; Telmisartan; Time Factors; Trans-Activators; Transcription Factors | 2012 |
Does the PPAR-γ-activating property of telmisartan provide a benefit in clinical practice?
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus; Glucose; Homeostasis; Humans; Hypertension; Insulin; PPAR gamma; Telmisartan; Treatment Outcome | 2013 |
Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
Topics: Adiponectin; Adipose Tissue; Animals; Benzimidazoles; Benzoates; Body Weight; Diabetes Mellitus; Eating; Fatty Acid Synthases; Fatty Acid-Binding Proteins; Gene Expression Regulation; Homeostasis; Insulin Resistance; Interleukin-6; Male; Mice; Mice, Obese; PPAR gamma; RNA, Messenger; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan | 2002 |
Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; PPAR gamma; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Potential effects of angiotensin II receptor blockers on glucose tolerance and adiponectin levels in hypertensive patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Middle Aged; PPAR gamma; Telmisartan | 2007 |